 |
|
New ACC/AHA guidelines released for valvular heart disease
June 16, 2006An updated set of guidelines jointly released by the American College of Cardiology (ACC) and the American Heart Association (AHA) draws together the latest information on the diagnosis and treatment of patients with valvular heart disease. The new document is slated for release at ACC's Heart Valve Summit in Chicago.
Valve disease most often strikes the mitral valve, which controls blood flow between the left atrium and the left ventricle, or the aortic valve (most prevalent type), which controls blood flow between the left ventricle and the aorta, the large artery that supplies blood to the rest of the body. Valvular heart disease caused about 20,000 deaths in 2003. The total mentioned mortality (i.e., underlying or contributing number of deaths) is about 42,500. There were 95,000 first-listed hospital discharges in 2003 for valvular heart disease. An estimated 95,000 inpatient valve procedures were performed in the United States in 2003.
The guidelines discuss evaluating patients with heart murmurs, preventing and treating endocarditis, managing valve disease in pregnancy, and treating patients with concomitant coronary artery disease, as well as more specialized issues regarding specific valve lesions.
"These guidelines highlight major advances in noninvasive testing and surgery for patients with valvular heart disease," said Robert O. Bonow, M.D., lead author of the joint statement, chief of cardiology at Northwestern Memorial Hospital and the Goldberg Distinguished Professor of Cardiology at Northwestern University's Feinberg School of Medicine in Chicago. "There have always been areas of uncertainty and differences of opinion on how to diagnose and treat patients with valvular heart disease. Today we have more much solid data to draw on."
The new guidelines update an earlier set released in 1998. One of the key changes in the 2006 document is a focus on the proper timing of valve surgery. The guidelines include more precise and quantitative definitions of mild, moderate and severe valvular disease, based on the patient's symptoms and the results of exercise testing, echocardiography, and other tests. This change may prompt earlier referral of some patients for surgery, even before they develop noticeable symptoms.
"The guidelines encourage physicians to look behind the scenes, rather than waiting for symptoms to develop," said Patrick T. O'Gara, M.D., director of clinical cardiology at Brigham & Women's Hospital and an associate professor of medicine at Harvard Medical School, Boston. "For example, an abnormal response to exercise could help identify patients with aortic stenosis who may be candidates for surgery sooner rather than later."
Other highlights of the guidelines include:
- Surgical advances that increasingly permit repair, rather than replacement, of heart valves in many patients. These are particularly important for some patients with leaky mitral valves and are increasingly used in selected patients with aortic valve regurgitation.
- The use of echocardiography in the operating room to guide surgery. This procedure, known as transesophageal echocardiography, involves passing a probe into the esophagus and using sound waves to create real-time pictures of the heart.
- Further clarification of the use of blood thinners in patients who have undergone heart valve surgery.
- An update on preventive medical treatment for some heart valve conditions.
The guidelines also acknowledge the complexity of managing many patients with valvular heart disease, including the selection of replacement heart valves. For example, a young woman who has surgery to replace a diseased heart valve with a mechanical heart valve would need blood-thinning medications to prevent blood clotting and stroke. If she became pregnant, blood thinners would pose a toxic risk to the fetus. Implanting a biological heart valve would eliminate the need for blood thinners, but it would be unlikely to last a lifetime, necessitating another open-chest surgery in the future.
"It is important for patients to understand that we have much better data today, but we still don't have all the answers," Dr. Bonow said. "Patients need to discuss their care with their physicians and play a major role in making treatment decisions."
The full text of the guidelines will be published online at www.acc.org and www.americanheart.org. A summary of the guidelines will be published in the August 1, 2006, issue of Journal of the American College of Cardiology, and the August 1, 2006, issue of Circulation: Journal of the American Heart Association.
American College of Cardiology
"These guidelines highlight major advances in noninvasive testing and surgery for patients with valvular heart disease," said Robert O. Bonow, M.D., lead author of the joint statement, chief of cardiology at Northwestern Memorial Hospital and the Goldberg Distinguished Professor of Cardiology at Northwestern University's Feinberg School of Medicine in Chicago. "There have always been areas of uncertainty and differences of opinion on how to diagnose and treat patients with valvular heart disease. Today we have more much solid data to draw on."
The new guidelines update an earlier set released in 1998. One of the key changes in the 2006 document is a focus on the proper timing of valve surgery. The guidelines include more precise and quantitative definitions of mild, moderate and severe valvular disease, based on the patient's symptoms and the results of exercise testing, echocardiography, and other tests. This change may prompt earlier referral of some patients for surgery, even before they develop noticeable symptoms.
"The guidelines encourage physicians to look behind the scenes, rather than waiting for symptoms to develop," said Patrick T. O'Gara, M.D., director of clinical cardiology at Brigham & Women's Hospital and an associate professor of medicine at Harvard Medical School, Boston. "For example, an abnormal response to exercise could help identify patients with aortic stenosis who may be candidates for surgery sooner rather than later."
Other highlights of the guidelines include:
- Surgical advances that increasingly permit repair, rather than replacement, of heart valves in many patients. These are particularly important for some patients with leaky mitral valves and are increasingly used in selected patients with aortic valve regurgitation.
- The use of echocardiography in the operating room to guide surgery. This procedure, known as transesophageal echocardiography, involves passing a probe into the esophagus and using sound waves to create real-time pictures of the heart.
- Further clarification of the use of blood thinners in patients who have undergone heart valve surgery.
- An update on preventive medical treatment for some heart valve conditions.
The guidelines also acknowledge the complexity of managing many patients with valvular heart disease, including the selection of replacement heart valves. For example, a young woman who has surgery to replace a diseased heart valve with a mechanical heart valve would need blood-thinning medications to prevent blood clotting and stroke. If she became pregnant, blood thinners would pose a toxic risk to the fetus. Implanting a biological heart valve would eliminate the need for blood thinners, but it would be unlikely to last a lifetime, necessitating another open-chest surgery in the future.
"It is important for patients to understand that we have much better data today, but we still don't have all the answers," Dr. Bonow said. "Patients need to discuss their care with their physicians and play a major role in making treatment decisions."
The full text of the guidelines will be published online at www.acc.org and www.americanheart.org. A summary of the guidelines will be published in the August 1, 2006, issue of Journal of the American College of Cardiology, and the August 1, 2006, issue of Circulation: Journal of the American Heart Association.
American College of Cardiology
UCSF marks a milestone with 500th transplant in heart and lung program
UCSF marked a milestone this week with the 500th procedure in its Thoracic Transplant Program, which specializes in transplantation of the heart and lung.
Most patients don't need antibiotics before dental procedures
Taking a precautionary antibiotic before a trip to the dentist isnˇ¦t necessary for most people, and in fact, might create more harm than good, according to updated recommendations from the American Heart Association.
Mitral valve surgery may be safe option for elderly patients
Deaths among elderly patients undergoing mitral valve surgery have decreased dramatically in recent years - making the procedure a feasible option.
ESC Congress 2004: Atrial fibrillation patients often receive needless treatment
On behalf of the Euro Heart Survey on AF study group Management of AF in ESC countries: first lessons from the EuroHeartSurvey
ESC Congress 2003: Acute Heart Failure Guidelines
IMPORTANT: This press release accompanies a presentation given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Acute Heart Failure Guidelines
More Valvular Heart Disease Current Events and Valvular Heart Disease News Articles
 |
Valvular Heart Disease: A Companion to Braunwald's Heart Disease: Expert Consult - Online and Print by Catherine M. Otto MD (Author), Robert O. Bonow MD (Author) Valvular Heart Disease is now an even better source for all your questions on dysfunctions or abnormalities of the heart's four valves. In the third edition, Catherine Otto is joined by Robert Bonow and a team of expert contributors to bring you the latest developments in imaging and treatment. The full-color images and illustrations reflect the cutting-edge imaging and diagnostic modalities-Doppler echo and MR-that are so important for diagnosing aortic valve defects. Superb diagrams, an increased focus on imaging and case-based presentation, and new chapters-on Cardiac MR and CT imaging for valvular heart disease; Genetic, molecular and cellular mechanisms of valvular disease; Bicuspid aortic valve disease; and Ischemic mitral regurgitation-further enhance this valuable reference. And,... |
 |
Valvular Heart Disease (Contemporary Cardiology) by Andrew Wang (Editor), Thomas M. Bashore (Editor) Challenges for the treatment of valvular heart disease include the growing need for effective yet less invasive interventions and therapies to treat these progressive conditions. With the development of potential new treatments, it is crucial for cardiac |
|
Netter's Cardiology Vol 3: Valvular Heart Disease & Pericardial Diseases by Netter's Cardiology This features chapters V and VI of Netter's Cardiology. It is volume 3 and contains V: Valvular Heart Disease and VI: Pericardial Diseases. Below are the individual chapters in this volume: V. VALVULAR HEART DISEASE Section Editor: Thomas M. Bashore Chapter 27: Aortic Stenosis 256 Timothy A. Mixon and Gregory J. Dehmer Chapter 28: Aortic Insufficiency 265 Timothy A. Mixon and Gregory J. Dehmer Chapter 29: Mitral Valve Disease 274 Thomas R. Griggs Chapter 30: Mitral Valve Prolapse 283 Lee R. Goldberg and Park W. Willis IV Chapter 31: Tricuspid and Pulmonic Valve Disease 290 David A. Tate Chapter 32: Infective Endocarditis 296 Lisa B. Hightow and Meera Kelley Chapter 33: Percutaneous Balloon Valvuloplasty 308 Thomas M. Bashore Chapter 34: Surgical Treatment for Valvular Heart Disease 324... | |
 |
Heart Failure Heart failure, also called congestive heart failure, is a condition in which the heart cannot pump enough oxygenated blood to meet the needs of the body?s other organs. The heart keeps pumping, but not as efficiently as a healthy heart. Usually, the loss in the heart?s pumping action is a symptom of an underlying heart problem. Heart failure affects nearly 5 million US adults. It is on the rise with an estimated 400,000 to 700,000 new cases each year. This talk will focus on the causes, symptoms, diagnosis and treatments available for heart failure, including current research findings from Stanford. |
 |
Valvular Heart Disease in Clinical Practice by Michael Y. Henein (Editor) There is a need for all medical practitioners to be aware of the signs and symptoms of valve disease. The management of valvular disease is dominated by thorough investigations and optimum treatment. Valvular Heart Disease in Clinical Practice provides a toolkit for clinicians to guide them in the diagnosis and treatment of patients with suspected valvular heart disease. Algorithms and flow diagrams are included to give the reader an illustrated snapshot of the decisions involved in the management of these patients. |
 |
100 Q&A About Valvular Heart Disease (100 Questions & Answers about) by Ramdas Pai (Author) Empower yourself!Whether you're a newly diagnosed patient with valvular heart disiease, a survivor, or friend or relative of someone with valvular heart disease, this book offers help. 100 Questions & Answers About Valvular Heart Disease gives you authoritative, practical answers to your questions about treatment options and provides sources of support from both the doctor's and patient's viewpoints. Included are improved surgical procedures, noninvasive techniques for surveillance of left ventricular function, guidelines for the timing of surgery, and the role of drug therapy in the management of valvular heart disease. This book is an invaluable resource for anyone coping with the physical and emotional turmoil of this disease. |
 |
Valvular Heart Disease by Bruce Andrus (Author) The authors aim to provide a concise and straightforward guide to the recognition and management of valvular heart disease, complemented by current guidelines and abundant high quality images. This book will be a valuable reference for all involved in the care of patients with valvular heart disease, including cardiologists in practice and training, young hospital doctors, general physicians, cardiac nurse specialists, and medical students. |
 |
Valvular Heart Disease (Fundamental and Clinical Cardiology) by Al-Zaibag (Author) This useful reference provides up-to-the-minute coverage of every aspect of valvular heart disease–presenting etiology, pathophysiology, and symptomatology in detail as well as current methods of diagnosis and treatment. Examines specific problems in valvular heart disease such as endocarditis, pregnancy, arrhythmias, rheumatic disease, acute regurgitation, and surgery in children and the elderly! Reviewing the latest invasive and non-invasive diagnostic techniques and analyzing the wide variety of management choices, Valvular Heart Disease explicates the pathology, echocardiography, and the radiological examination of valvular diseases discusses each of the heart valves elucidates possible pitfalls in diagnosis and management shows how to assess left and right ventricular... |
 |
Dx/Rx: Valvular Heart Disease (Dx/Rx Series) by Dennis A., M.D. Tighe (Author), Theo E., M.D. Meyer (Author), Gerard P., M.D. Aurigemma (Author) Tightly organized into a super-condensed outline bulleted format, this handy, pocket-sized manual details precise, up-to-date information for diagnosis and treatment of Valvular Heart Disease. Throughout the book, tables and figures summarize important clinical data and current professional society recommendations, while salient references direct readers to additional information. Current, quick, and concise, for instant access on the ward or in the clinic! |
|
Valvular Heart Disease: Pathologic, Echocardiographic and Surgical Correlations by Lawrence J. Freant (Author), Carolyn K. Landolfo (Author), Kevin P. Landolfo (Author) To most physicians who completed their medical training within the last 40 years, few areas of medicine have seen more dramatic changes than in the diagnostic evaluation and treatment of valvular heart disease. Earlier in this century, because of the high worldwide incidence of rheumatic fever, almost all examples of valve stenosis or incompetence were assumed to have a rheumatic basis. Indeed, except for the occasional necropsy case demonstrating either a congenitally malformed valve or one structurally altered by other more virulent infectious processes, these assumptions were often accurate. Nowadays, however, with the advent of more sophisticated modalities such as doppler echo cardiography and color flow imaging techniques earlier medical and surgical interventions are possible. |
| © 2009 BrightSurf.com |